In the European tech ecosystem, we have a Series B problem, and it’s not new. We are excellent at launching startups with Seed funding, but many struggle to maintain the velocity required to become global leaders.
There are many reasons for this, but from a PR perspective, the missing ingredient is often the architecture of credibility.
Most founders treat their funding announcement as the finish line of a PR campaign. In reality, it is the starting point. If you want to move from ‘startup’ to ‘category leader,’ you must pivot quickly from the funding narrative to the authority narrative. Ideally, you want to do that within six months of your raise.
The most effective tool for that pivot is one that most founders underestimate: the strategic keynote.
The hype curve is a wasting asset
In the weeks following a funding announcement, founders enjoy a brief window of earned attention. Journalists are responsive. Investors are curious. Talent is paying attention. But this hype depreciates fast, typically within six to eight weeks.
The question is not whether you have a story to tell. It’s whether you are converting that moment of attention into durable social capital or letting it evaporate into a few press mentions and a LinkedIn post.
Strategic speaking is one of the ways you make the conversion. Done well, a keynote placement at the right event can do more for perceived valuation, talent acquisition, and enterprise sales than a dozen press releases.
Three things a keynote does that a PR cannot
For DeepTech and BioTech founders especially, the case for keynote investment is structural, not cosmetic. First, it helps distil complexity. The problems worth solving in tech rarely fit in 280 characters. A keynote gives a founder the time and format to build a world around their problem, to make the solution feel not just plausible, but inevitable. That is a narrative move no press release can make.
A keynote creates a halo effect and instantly builds your social capital. Who you share a stage with matters as much as what you say.
Being moderated by a respected editor or speaking alongside a recognised clinician or investor provides instant institutional credibility. You cannot buy this, but you can engineer it.
Lastly, it provides you with a permanent sales infrastructure. A recorded keynote outlives the event. It becomes a recruiting asset, a sales tool, a media reference, and a signal to future investors. The compounding value of a single 20-minute talk is consistently underestimated.
What conference organisers are actually looking for
The founders who land main-stage spots are not always the most funded or the best known. They are the ones who pitch a perspective, not a product. They are looking for what we call category shifters. They want speakers who can completely overturn the frame of a debate, not just contribute to it. That means your pitch to an event organiser should lead with a provocation or a counter-intuitive thesis, not a company overview.
Here are three moves that work, and they can be a mix of them.
- The category shift: Position yourself not as a company, but as the vanguard of a movement. Talk about how the world is changing, why the old guard cannot keep up, and what the new model looks like. Your company becomes evidence, not the subject.
- The coalition approach: Propose a panel, not a solo slot. Bring a practitioner, a patient advocate, and a scientist. This makes you the convener of a conversation rather than a spokesperson for your own company, a meaningfully different positioning.
- The momentum hook: Use your funding news as proof of relevance, not the pitch itself. Organisers want speakers who are “hot” in the venture cycle. The raise is the credential; the idea is the pitch.
The European founder’s specific imperative
For European founders, there is an additional layer of urgency. The default assumption in global markets, particularly in the US, is still that category-defining companies come from the Bay Area. That assumption is changing, but it does not change passively.
Dominating stages at events like HLTH, Tech Open Air, VivaTech, or Health.tech Basel is one of the fastest ways to lose the “local” label.
When a European founder is consistently on global stages, moderating panels, setting agendas, and being cited by others, the geography becomes irrelevant. The signal is authority, and authority travels.
Funding is the fuel. Voice is the engine.
The work we do in the months after a raise is often more consequential than the announcement itself. A funding headline puts you on the map. What you say next, from which stages, to which audiences, in which framing, determines whether you become a category leader or a well-funded footnote.
The founders who understand this early move faster, attract better talent, and close harder deals. Oftentimes, the ones who don’t tend to spend the next raise rebuilding the credibility they failed to compound the first time around.
Your voice is not a vanity asset. It is a strategic infrastructure. Treat it accordingly.
